CClinicalTrials.gg
CompletedNCT06879522BCS_MAXUpdated Apr 7, 2026

Maximizing Energy and Reducing Fatigue in Breast Cancer Survivors

An interventional study of Maximizing Energy Intervention and Health Education in Breast Cancer Survivor and Cancer Related Fatigue, sponsored by University of Pittsburgh. Completed at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-07.

Sponsored by University of Pittsburgh · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

This study is testing a program called Maximizing Energy to see if it can help women who have finished breast cancer treatment manage their fatigue. The study has two main goals:

  1. Check if the program can be successfully delivered - Researchers will see if women are willing to join and stay in the study, if they follow the program, and if they find it helpful.
  2. See if the program works - Researchers will compare Maximizing Energy to a general health education program to see which one helps reduce cancer-related fatigue better.

Participant will:

  1. Take tests to see if they qualify and to measure their fatigue.
  2. Be randomized to receive Maximizing Energy or Health Education Interventions for 6 sessions over the internet
  3. After the sessions and again one month later, repeat some tests to see if their fatigue has improved.
02

Conditions studied

  • Breast Cancer Survivor
  • Cancer Related Fatigue

Keywords

  • self-management
  • problem solving therapy
  • actigraphy
  • occupational therapy
03

In context

Lead sponsor

University of Pittsburgh is the lead sponsor of 1,385 studies on the registry; 167 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 4 (50%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • adult (18 years and older) pre and post-menopausal female at birth diagnosed with Stages I-IIIa breast cancer,
  • completed primary treatment for breast cancer (surgery, chemotherapy, radiation) at least 6 months prior to ensure that fatigue is stable and chronic, - moderate to severe fatigue based on score ≥ 4 on the 7-point Fatigue Severity Scale,
  • able to speak and understand English
  • has a mobile device that runs on the Apple or Android platform

Exclusion criteria

Exclusion Criteria:

  • major depressive disorder, mania, hypomania, psychosis, or substance abuse in the past 3 months and
  • disability due to diagnoses other than breast cancer.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
15 participants (actual)

Study arms

  • Experimental
    Maximizing Energy

    Maximizing Energy

    Behavioral: Maximizing Energy Intervention

  • Active comparator
    Health Education

    Health Education

    Behavioral: Health Education

Interventions

  • BehavioralMaximizing Energy Intervention

    A licensed occupational therapist will deliver the intervention. The Maximizing Energy program combines problem-solving therapy (PST) and energy conservation education. Participants will participate in 6 virtual once/week sessions for 30 minutes. The introductory session, they will track their fatigue and identify three key fatigue-related problems. In session 2, they will prioritize one problem and practice problem-solving steps. They then implement an action plan and review progress in the next session. If the solution is ineffective, the therapist helps modify it or create a new one. If successful, the participant moves to the next problem. A MAX workbook supports learning, covering intervention details, fatigue education, energy conservation strategies, and problem-solving worksheets. The goal is to help participants apply these strategies to improve daily life and return to work.

  • BehavioralHealth Education

    To control for the effects of interactions with an interventionist, participants in the attention control group will receive the Health Education intervention. The interventionists will review a workbook covering fatigue, energy conservation, healthy eating, exercise, and relaxation. Like the MAX intervention, Health Education will be delivered virtually in weekly 30-minute one-on-one sessions for six weeks. The interventionist provides education on breast cancer-related fatigue, diet, safe physical activities, and energy conservation strategies tailored to individual needs. A workbook will support learning.

06

What researchers measure

Primary outcomes

  1. Retention in the study

    The proportion of participants who remain in the study until its completion relative to those initially enrolled. The retention rate will be calculated separately for the Maximizing Energy and Control Groups using the following formula: (number of participants who completed the study/number of participants initially enrolled)X 100

    Time frame: Baseline to Week 11 (4 weeks post-intervention)

  2. Participant Adherence to treatment: Receipt

    The investigators will collect data on the number of intervention sessions attended by participants

    Time frame: Week 7 (post-6-week intervention)

  3. Participant Adherence to treatment: Receipt

    Interventionists will rate participant's active engagement in the interventions on the Pittsburgh Participant Rating Scale. Each session will be scored 1 (no engagement, refusal) to 6 (excellent engagement) by the interventionist conducting the sessions.

    Time frame: Week 7 (post-6-week intervention)

  4. Participant Adherence to treatment: Enactment

    The investigators will collect interventionist rating of whether participant completed action plan from previous session (3-point scale; 0 = not completed, 2 = plan completed) for the MAX Intervention group only.

    Time frame: Week 7(post-6-week intervention)

  5. Participant Satisfaction with Intervention

    Client satisfaction is measured using the Client Satisfaction Questionnaire. The Clients Satisfaction Questionnaire is an 8-item assessment of satisfaction with the intervention program, rated on a 4-point scale that ranges from 1 to 4 in each item. Higher scores indicate greater satisfaction with the intervention.

    Time frame: Week 7(post-6-week intervention)

  6. Intervention Fidelity

    All intervention sessions will be video recorded and a random 20 percent will be rated by independent evaluators trained by the principal investigator. Intervention fidelity for both groups will be assessed using the PST Provider Checklist. The a priori criterion for adequate fidelity was that equal or greater than 80 percent of intervention sessions are rated with equal or greater than 80 percent of adequate fidelity for the MAX Intervention group while less than 20 percent of intervention sessions are rated with equal or lesser than 20 percent of adequate fidelity for the Health Education group.

    Time frame: Week 7(post-6-week intervention)

  7. Changes in fatigue

    The PROMIS® Item Bank v1.0 - Fatigue - Short Form 13a (FACIT-Fatigue) is a 13-item questionnaire designed to assess fatigue levels and their impact on daily activities and quality of life. Each item is scored on a 5-point Likert scale (1 = not at all to 5 = very much), with a total score ranging from 13 to 65. Higher scores indicate greater fatigue, while lower scores suggest less fatigue and better energy levels.

    Time frame: Baseline to Week 11 (4 weeks post-intervention)

Secondary outcomes

  1. Changes in resilience

    The Connor-Davidson Resilience Scale (CD-RISC) is a tool designed to measure an individual's resilience, or ability to adapt to stress and adversity. It consists of 25 items, each rated on a 5-point Likert scale (0 = not true at all to 4 = true nearly all the time), with total scores ranging from 0 to 100. Higher scores indicate greater resilience, reflecting stronger coping skills and adaptability in challenging situations.

    Time frame: Baseline to Week 11 (4 weeks post-intervention)

  2. Changes in impact of fatigue in daily life

    The Modified Fatigue Impact Scale (MFIS) is a 21-item questionnaire that assesses the impact of fatigue on physical, cognitive, and psychosocial functioning. Each item is rated on a 5-point Likert scale (0 = never to 4 = almost always), with a total score ranging from 0 to 84. Higher scores indicate a greater negative impact of fatigue on daily life, while lower scores suggest minimal interference with functioning.

    Time frame: Baseline to Week 11 (4 weeks post-intervention)

  3. Changes in fatigue severity

    The Fatigue Severity Scale (FSS) is a 9-item questionnaire designed to assess the impact of fatigue on daily life and functioning. Each item is rated on a 7-point Likert scale (1 = strongly disagree to 7 = strongly agree), with total scores ranging from 9 to 63. Higher scores indicate greater fatigue severity and its interference with daily activities, while lower scores suggest minimal fatigue impact.

    Time frame: Baseline to Week 11 (4 weeks post-intervention)

  4. Change in physical activity: Step Count

    The investigators will collect data on physical activity as a surrogate measure of increase in energy. The ActiGraph wGT3X-BT® is a validated accelerometer used to measure physical activity outcomes, including step count. The ActiGraph wGT3X-BT will be worn on the wrist for 5 days to yield three 24 hour data for a mean number of steps taken daily.

    Time frame: Baseline to Week 11 (4 weeks post-intervention)

  5. Change in Physical Activity: Energy Expenditure

    The investigators will collect data on physical activity as a surrogate measure of increase in energy. The ActiGraph wGT3X-BT® is a validated accelerometer used to measure physical activity outcomes, including energy expenditure. The ActiGraph wGT3X-BT will be worn on the wrist for 5 days to yield three 24 hour data for a mean energy expenditure daily.

    Time frame: Baseline to Week 11 (4 weeks post-intervention)

  6. Change in physical activity: Intensity of Activity

    The investigators will collect data on physical activity as a surrogate measure of increase in energy. The ActiGraph wGT3X-BT® is a validated accelerometer used to measure physical activity outcomes, including percentage of time spent in sedentary, light, moderate, and vigorous physical activity. The ActiGraph wGT3X-BT will be worn on the wrist for 5 days to yield three 24 hour data for a percentage of time spent in different intensity activity daily.

    Time frame: Baseline to Week 11 (4 weeks post-intervention)

Other outcomes

  1. Commonly used strategies to manage fatigue

    The Energy Conservation Strategies Survey assesses which energy conservation strategies they have used in the past 6 weeks and how effective they perceive these strategies to be in managing their fatigue. The survey lists 14 strategies. Strategy effectiveness in managing fatigue is rated on a 10-point scale with 1 indicating not effective and 10 indicating very effective.

    Time frame: Baseline to 4-weeks after intervention completion

07

Study locations

1 site
  • University of Pittsburgh
    Pittsburgh, Pennsylvania 15219, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06879522
Lead sponsor
University of Pittsburgh
Responsible party
Ketki Raina (Professor, University of Pittsburgh) — Principal investigator
First posted
Mar 17, 2025
Start date
May 14, 2025
Primary completion
Jan 23, 2026
Completion
Feb 2, 2026
Last update
Apr 7, 2026

Study contacts

Ketki Raina, PhD, OTR/L, FAOTA
principal investigator · University of Pittsburgh

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion